A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2004
The purpose of this study is to determine whether a simplified lopinavir-ritonavir based therapy will continue to keep the viral load to very low levels after initial treatment with a combination of Kaletra® (lopinavir/ritonavir) plus Combivir® (lamivudine/zidovudine).
Epistemonikos ID: d8932b3666e115227b09b6c0ad2e4ea13fa19a69
First added on: Dec 01, 2021